Titers of COVID-19 antibodies were lower for patients with CD4 cell counts of less than 200 cells/μL in the first, second, and third serological tests with statistical significance; p = 0.0001 for the first titer (Table 2). This evidence concerns the gene CD4 and COVID-19.